These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9169736)

  • 21. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
    Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P
    Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.
    Kossaczka Z; Shiloach J; Johnson V; Taylor DN; Finkelstein RA; Robbins JB; Szu SC
    Infect Immun; 2000 Sep; 68(9):5037-43. PubMed ID: 10948122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of immunogenic conjugates of Salmonella enterica serovar Typhi O-specific polysaccharides with diphtheria toxoid.
    Ali A; An SJ; Cui C; Haque A; Carbis R
    Hum Vaccin Immunother; 2012 Feb; 8(2):189-93. PubMed ID: 22426380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.
    Fattom A; Vann WF; Szu SC; Sutton A; Li X; Bryla D; Schiffman G; Robbins JB; Schneerson R
    Infect Immun; 1988 Sep; 56(9):2292-8. PubMed ID: 3410538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi.
    Szu SC; Li XR; Schneerson R; Vickers JH; Bryla D; Robbins JB
    Infect Immun; 1989 Dec; 57(12):3823-7. PubMed ID: 2807549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM
    Micoli F; Bjarnarson SP; Arcuri M; Aradottir Pind AA; Magnusdottir GJ; Necchi F; Di Benedetto R; Carducci M; Schiavo F; Giannelli C; Pisoni I; Martin LB; Del Giudice G; MacLennan CA; Rappuoli R; Jonsdottir I; Saul A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24443-24449. PubMed ID: 32900928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.
    Szu SC; Hunt S; Xie G; Robbins JB; Schneerson R; Gupta RK; Zhao Z; Tan X
    Vaccine; 2013 Apr; 31(15):1970-4. PubMed ID: 23422143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.
    Micoli F; Rondini S; Pisoni I; Proietti D; Berti F; Costantino P; Rappuoli R; Szu S; Saul A; Martin LB
    Vaccine; 2011 Jan; 29(4):712-20. PubMed ID: 21115057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
    Tacket CO; Ferreccio C; Robbins JB; Tsai CM; Schulz D; Cadoz M; Goudeau A; Levine MM
    J Infect Dis; 1986 Aug; 154(2):342-5. PubMed ID: 2425009
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi.
    Rondini S; Micoli F; Lanzilao L; Hale C; Saul AJ; Martin LB
    Clin Vaccine Immunol; 2011 Mar; 18(3):460-8. PubMed ID: 21248155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
    An SJ; Scaria PV; Chen B; Barnafo E; Muratova O; Anderson C; Lambert L; Chae MH; Yang JS; Duffy PE
    Vaccine; 2018 May; 36(21):2978-2984. PubMed ID: 29681410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2001 Jan; 69(1):297-306. PubMed ID: 11119518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.
    Fattom A; Schneerson R; Watson DC; Karakawa WW; Fitzgerald D; Pastan I; Li X; Shiloach J; Bryla DA; Robbins JB
    Infect Immun; 1993 Mar; 61(3):1023-32. PubMed ID: 8432585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between structure and immunologic properties of the Vi capsular polysaccharide.
    Szu SC; Li XR; Stone AL; Robbins JB
    Infect Immun; 1991 Dec; 59(12):4555-61. PubMed ID: 1937814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
    Arcuri M; Di Benedetto R; Cunningham AF; Saul A; MacLennan CA; Micoli F
    PLoS One; 2017; 12(12):e0189100. PubMed ID: 29287062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.
    Devi SJ; Schneerson R; Egan W; Ulrich TJ; Bryla D; Robbins JB; Bennett JE
    Infect Immun; 1991 Oct; 59(10):3700-7. PubMed ID: 1716613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
    Wang JY; Noriega FR; Galen JE; Barry E; Levine MM
    Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.
    Jin Z; Bohach GA; Shiloach J; Norris SE; Freedberg DI; Deobald C; Coxon B; Robbins JB; Schneerson R
    Infect Immun; 2005 Dec; 73(12):7887-93. PubMed ID: 16299279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
    N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.